Alzprotect Press Releases

• Published on June 1, 2022 - 19:18 GMT

  

  Alzprotect Awarded a Grant from The Michael J. Fox Foundation to Advance Small Molecule Parkinson’s Disease Program

  Alzprotect, a French biopharmaceutical company has been awarded a USD $338,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) LOOS, HAUTS DE FRANCE, FRANCE, June 1, 2022 /⁨EINPresswire.com⁩/ -- Alzprotect, a French …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on June 22, 2021 - 10:17 GMT

  

  Alzprotect strengthens its Board of Directors with the arrival of Dr. John Tchelingerian

  ALZPROTECT announced Dr. John Tchelingerian has joined the Board of Directors of Alzprotect. LOOS, HAUTS DE FRANCE, FRANCE, June 22, 2021 /⁨EINPresswire.com⁩/ -- ALZPROTECT, a biopharmaceutical company engaged in the development of drugs for the treatment …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on May 11, 2021 - 08:00 GMT

  

  Alzprotect et l’Hôpital Fondation Rothschild annoncent la signature d’une collaboration contre la neurodégénération

  Alzprotect et l’Hôpital Fondation Rothschild annoncent la signature d’une collaboration dans le cadre d’un test clinique de phase 2 pour le traitement de la PSP LILLE, HDF, FRANCE, May 11, 2021 /⁨EINPresswire.com⁩/ -- Alzprotect et l’Hôpital Fondation …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on April 8, 2021 - 12:56 GMT

  Alzprotect Establishes U.S. Subsidiary in Boston, in the Heart of the Biotech Cluster

  Alzprotect, a biopharmaceutical company developing solutions for neurodegenerative diseases, announced today the creation of its U.S. subsidiary in Boston. LOOS, HDF, FRANCE, April 8, 2021 /⁨EINPresswire.com⁩/ -- Alzprotect establishes U.S. subsidiary in …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...